Cam Gallagher - 08 Sep 2026 Form 4 Insider Report for Opus Genetics, Inc. (IRD)

Reporting relationship: Director
Issuer ticker: IRD
Reported as of: 08 Sep 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 08 Sep 2026, 16:05:55 UTC
Prior SEC filing: 22 Apr 2026
Source filing: View source filing
Reporting owner signature: /s/ Amy Rabourn, by Power of Attorney

Key filing fact

Cam Gallagher filed Form 4 for Opus Genetics, Inc. (IRD) on 08 Sep 2026.

Key facts

This page summarizes Cam Gallagher's Form 4 filing for Opus Genetics, Inc. (IRD).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 08 Sep 2026, 16:05.

Change

Previous filing in this sequence was filed on 22 Apr 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001557832 Primary reporting owner

Gallagher Cam

Relationship: Director
Address: C/O OPUS GENETICS, INC., 8 DAVIS DRIVE, SUITE 220, DURHAM
Signature: /s/ Amy Rabourn, by Power of Attorney
Signature date: 08 Sep 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

IRD transaction

Common Stock

Options Exercise

Transaction value
Shares: +784,314
Change %: +39%
Price: $1.15^*
Shares after: 2,800,111
Date: 08 Sep 2026
Ownership: Direct
Footnotes: F1

IRD holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 83,000
Date: 08 Sep 2026
Ownership: By Garret Gallagher - Custodian UTMA/UGMA
Footnotes: F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

IRD transaction Derivative

Warrant (right to buy)

Options Exercise

Transaction value
Shares: -784,314
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 08 Sep 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 784,314
Exercise price: $1.15
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

In conjunction with the exercise of the Warrant reported herein, the Reporting Person entered into a Lock-Up Agreement with the Issuer dated September 6, 2026 (the "Lock-Up Agreement"). Pursuant to the Lock-Up Agreement, among other terms, the Reporting Person agreed that, without the prior written consent of the Issuer, during the period beginning on September 6, 2026 and ending at the close of business 180 days after the issuance of the shares of Common Stock underlying the Warrant, the Reporting Person will not transfer or dispose of, directly or indirectly, any shares of Common Stock, or any securities convertible into or exercisable or exchangeable for Common Stock (including, without limitation, Common Stock or such other securities which may be deemed to be beneficially owned by the Reporting Person and securities which may be issued upon exercise of a stock option or warrant), as further described in the Lock-Up Agreement and subject to certain exclusions described therein.

Footnote F2

These securities are held of record by the Reporting Person as custodian for a minor child under the Uniform Transfer to Minors Act. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, if any, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Footnote F3

The Warrant was immediately exercisable upon its acquisition on March 24, 2025, subject to the Issuer's right to call the Warrant at any time beginning 30 days following the release of the Issuer's OPGx-BEST1 DUO-1001 Cohort 1 data upon achievement of (i) a volume weighted average price of the Issuer's Common Stock for 30 consecutive trading days of over $1.725 per share and (ii) the trading average daily volume for such 30 day period exceeding $150,000 per trading day.